UNP
38
2
GILD
56
6
AEE
51
-7
LOW
43
-6
UHS
55
3
HAL
50
2
SO
46
-5
AIV
37
-2
HD
28
-4
RCL
68
4
PVH
32
2
HCA
64
5
ISRG
71
4
MPC
38
2
LRCX
62
6
SCHW
64
6
FLS
61
13
FDX
74
3
V
52
2
BMY
76
2
UNP
38
2
GILD
56
6
AEE
51
-7
LOW
43
-6
UHS
55
3
HAL
50
2
SO
46
-5
AIV
37
-2
HD
28
-4
RCL
68
4
PVH
32
2
HCA
64
5
ISRG
71
4
MPC
38
2
LRCX
62
6
SCHW
64
6
FLS
61
13
FDX
74
3
V
52
2
BMY
76
2
Financhill
Back

Palisade Bio, Inc. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
36

PALI
Palisade Bio, Inc.

Last Price:
$1.84
Seasonality Move:
-1.59%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.68
Seasonality Move:
-18.07%
Sell
36
Palisade Bio, Inc. (PALI) is a Sell

Is Palisade Bio, Inc. a Buy, Sell or Hold?

  • The current Palisade Bio, Inc. [PALI] share price is $1.83. The Score for PALI is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • PALI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PALI Stock Price Chart

What is Palisade Bio, Inc.'s stock price today?

  • The Palisade Bio, Inc. share price today is $1.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PALI is experiencing buying pressure, which is a positive indicator for future bullish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.

PALI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 48.4 Sell
Chaikin Money Flow: 6352780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.77 - 2.17) Sell
Bollinger Bands (100): (0.8 - 1.98) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.79 Sell
Chaikin Money Flow: 9780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.35) Sell
Bollinger Bands (100): (12.23 - 15.15) Sell

PALI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.87 Sell
20-day SMA: 1.93 Sell
50-day SMA: 1.9 Sell
200-day SMA: 1.08 Buy
8-day EMA: 0.92 Buy
20-day EMA: 0.45 Buy
50-day EMA: 0.2 Buy
200-day EMA: 0.05 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.09 Sell
20-day SMA: 11.62 Sell
50-day SMA: 12.8 Sell
200-day SMA: 11.89 Sell
8-day EMA: 11.86 Sell
20-day EMA: 11.96 Sell
50-day EMA: 12.6 Sell
200-day EMA: 12.22 Sell

Palisade Bio, Inc. Earnings Growth & PALI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.02 per share, and an increase next year of $0.45 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Palisade Bio, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):